FrançaisNOVACYT EXPANDS DEVELOPMENT PARTNERSHIP WITH IMMUNEXPRESS
Extension of contract continues multi-year assay design and development programVisit Page
Category: Uncategorized
Funding update
Funding update Paris, France and Camberley, UK – 26 February 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on its current position and funding plans. The Company confirms that 2019 trading has started positively and is in line with 2019 management expectations. The Company also continues
Visit PageNOVACYT REVENUES FULL YEAR 2018
Novacyt revenues full year 2018 Paris, France and Camberley, UK – 22 January 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited revenues for the full year ended 31 December 2018.
Visit Page